{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-23-028551","form_type":"8-K","ticker":"ADMA","cik":"0001368514","company_name":"ADMA BIOLOGICS, INC.","filed_at":"2023-06-06T23:59:59+00:00","discovered_at":"2026-05-14T18:03:38.586365+00:00","generated_at":"2026-06-14T06:26:54.312053+00:00","sec_items":["5.07","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"ADMA Biologics stockholders elect director and ratify auditor at 2023 annual meeting","bullets":["Bryant E. Fong elected Class I director with 104,032,764 votes for, 43,796,163 withheld, 31,645,337 broker non-votes.","Ratification of CohnReznick LLP as independent auditor for FY 2023: 178,835,482 for, 407,959 against, 230,823 abstain.","Quorum of 179,474,264 shares represented out of 222,249,295 outstanding as of April 10, 2023 record date."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-23-028551","json":"https://secwatch.observer/filing/0001140361-23-028551.json","markdown":"https://secwatch.observer/filing/0001140361-23-028551.md","text":"https://secwatch.observer/filing/0001140361-23-028551.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1368514/000114036123028551/0001140361-23-028551-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1368514/000114036123028551/brhc20054100_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-14T06:26:54.312053+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"16d071b302cf73a9b3b91b2a042327033788fda7","claim":"ADMA BIOLOGICS, INC. shareholders approved Election of Bryant E. Fong to serve as a Class I director until the Company’s 2026 Annual Meeting of Stockholders and until his successor is duly elected and qualified, or until his earlier resignation, removal or death at the 2023-06-06 meeting.","evidence_excerpt":"The vote with respect to the election of the director was as follows: Nominee For Withheld Broker Non-Votes Bryant E. Fong 104,032,764 43,796,163 31,645,337","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1368514/000114036123028551/0001140361-23-028551-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"director election"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-06-06"}],"fact_type":"shareholder_vote"},{"claim_id":"68e48abaaf405ad53773fbae31fa917144390d22","claim":"ADMA BIOLOGICS, INC. shareholders approved Ratification of the appointment of CohnReznick LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2023 at the 2023-06-06 meeting.","evidence_excerpt":"The vote with respect to the ratification of the appointment of CohnReznick LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2023 was as follows: For Against Abstain 178,835,482 407,959 230,823","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1368514/000114036123028551/0001140361-23-028551-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"auditor ratification"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-06-06"}],"fact_type":"shareholder_vote"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}